Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00

FDA recall notice · announced July 18, 2018 · Sanofi-aventis U.s

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00

Reason for recall

Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.

Notes

Distribution: Nationwide
Lot/code information: Lot #: 7F021B, Exp 6/30/20
Quantity: 3214 prefilled pens
Status: Ongoing
Products in this recall event:
- Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewa (D-0925-2018)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.